Hoeiland Jesper 4
4 · Radius Health, Inc. · Filed Feb 26, 2019
Insider Transaction Report
Form 4
Hoiland Jesper
DirectorPresident and CEO
Transactions
- Award
Performance Stock Units
2019-02-22+71,000→ 71,000 totalExp: 2029-02-22→ Common Stock (71,000 underlying) - Award
Stock Option (Right to Buy)
2019-02-22+128,000→ 128,000 totalExercise: $19.18Exp: 2029-02-22→ Common Stock (128,000 underlying)
Footnotes (2)
- [F1]25% of the shares subject to the stock option shall vest on February 22, 2020, and the remaining shares shall vest in substantially equal monthly installments over the following three years, subject to continued service with RDUS through such dates.
- [F2]Each restricted stock unit represents a contingent right to receive one share of RDUS common stock. 50% of the restricted stock units shall vest upon the execution of a Board approved partnership for elacestrant within twelve months from the grant date of February 22, 2019, and, assuming such performance condition is achieved, the remaining restricted stock units shall vest on the third anniversary of the grant date of February 22, 2019, subject to continued service with RDUS through such dates.